Oroxylin A, a classical natural product, shows a novel inhibitory effect on angiogenesis induced by lipopolysaccharide.

[1]  N. Lu,et al.  Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway. , 2012, Toxicology letters.

[2]  K. Kiura,et al.  Targeting angiogenesis in cancer therapy. , 2011, Acta medica Okayama.

[3]  Z. Zuo,et al.  Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones. , 2011, Biopharmaceutics & drug disposition.

[4]  I. Julkunen,et al.  TLR ligands induce synergistic interferon-β and interferon-λ1 gene expression in human monocyte-derived dendritic cells. , 2011, Molecular immunology.

[5]  Q. Qi,et al.  Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo. , 2009, Toxicology.

[6]  Ling-Ling Yang,et al.  In vitro study of the tocolytic effect of oroxylin A from Scutellaria baicalensis root , 2009, Journal of Biomedical Science.

[7]  M. Sans,et al.  VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. , 2009, Gastroenterology.

[8]  R. Hu,et al.  Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells. , 2009, European journal of pharmacology.

[9]  P. Lin,et al.  Angiogenesis links chronic inflammation with cancer. , 2009, Methods in molecular biology.

[10]  W. Yeh,et al.  LPS/TLR4 signal transduction pathway. , 2008, Cytokine.

[11]  S. Landolfo,et al.  Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. , 2008, Gynecologic oncology.

[12]  Yong Yang,et al.  Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1. , 2007, Cancer letters.

[13]  L. Laroche,et al.  Relationship between angiogenesis and inflammation in experimental arthritis. , 2006, European cytokine network.

[14]  D. Walsh,et al.  Osteoarthritis, angiogenesis and inflammation. , 2005, Rheumatology.

[15]  A. Berger,et al.  A murine model of ex vivo angiogenesis using aortic disks grown in fibrin clot. , 2004, Microvascular research.

[16]  Y. Gho,et al.  Capsaicin Inhibits in Vitro and in Vivo Angiogenesis , 2004, Cancer Research.

[17]  A. Karsan,et al.  Bacterial lipopolysaccharide directly induces angiogenesis through TRAF6-mediated activation of NF-kappaB and c-Jun N-terminal kinase. , 2003, Blood.

[18]  D. Walsh,et al.  Inflammation and angiogenesis in osteoarthritis. , 2003, Arthritis and rheumatism.

[19]  P. Chien,et al.  Novel synthesis of flavonoids of Scutellaria baicalensis Georgi. , 2003, Chemical & pharmaceutical bulletin.

[20]  C. Bucana,et al.  Lipopolysaccharide‐induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion , 2002, International journal of cancer.

[21]  D. Sherer,et al.  Angiogenesis during implantation, and placental and early embryonic development. , 2001, Placenta.

[22]  L. Yang,et al.  Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation. , 2000, Biochemical pharmacology.

[23]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[24]  P. Schlag,et al.  Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14. , 1996, Blood.

[25]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.